CasCure Therapeutics is Drug Discovery in South Korea that focus on South Korea business. Founded in 2020. They cover business area such as developer, anti-cancer drug, cluster regularly interspace short palindromic repeat, CRISPR) technology, Ulsan, South Korea, artificial intelligence algorithm, deep learning technology, device, pipeline, Platform C, precision cancer medicine, Platform H, medical professional, a solution.
2020
( 4 years old in 2024 )
South Korea
-
Ulsan National Institute of Science and Technology
Ulsan
South Korea
Private
developeranti-cancer drugcluster regularly interspace short palindromic repeatCRISPR) technologyUlsanSouth Koreaartificial intelligence algorithmdeep learning technologydevicepipelinePlatform Cprecision cancer medicinePlatform Hmedical professionala solution
* We use standard office opening hours in near CasCure Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
CasCure Therapeutics is Drug Discovery business from South Korea that founded in 2020 (4 years old in 2024), CasCure Therapeutics business is focusing on South Korea.
CasCure Therapeutics headquarter office and corporate office address is located in Ulsan National Institute of Science and Technology Ulsan South Korea.
CasCure Therapeutics was founded in South Korea.
In 2024, CasCure Therapeutics is currently focus on South Korea sector.
Above is snippet of Google Trends for "South Korea" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with CasCure Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
